Tonix is developing innovative pharmaceutical products to address major public health challenges. In addition to Tonmya for PTSD, Tonix is developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (Investigational New Drug) application stage, designed as a daytime treatment for PTSD, and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage, to be developed as a potential smallpox-preventing vaccine.

Pharmaceutical

Tonix Pharmaceuticals

Tonix Pharmaceuticals' headquarters in New York, NY, United States

Seth Lederman

Irina Ishak

Jessica Edgar Morris

Bradley Saenger

Gregory Sullivan

Adeoye Olukotun

Margaret Smith Bell

Carolyn E. Taylor

Richard H. Bagger

R. Newcomb Stillwell

David Grange

James Treco

The Leadership Team at Tonix Pharmaceuticals is responsible for steering the company's strategic direction and overseeing the development of innovative pharmaceutical products. Comprising experts in finance, experimental chemistry, medical science, and product development, this team collaborates to ensure effective research, regulatory compliance, and operational excellence in bringing groundbreaking treatments, such as Tonmya and promising candidates like TNX-601 and TNX-801, to market. Their combined expertise drives Tonix's mission to address significant public health challenges.

Leadership Team

The Research and Development team at Tonix Pharmaceuticals is responsible for advancing the company's innovative pharmaceutical products from concept to clinical development. This includes conducting in vitro studies, developing and producing antibodies, managing clinical programs, analyzing intellectual property, ensuring quality assurance, planning and conducting biostatistical analysis, and overseeing analytical development. Their work supports the development of candidates like TNX-601 for PTSD and TNX-801 for smallpox prevention.

Research and Development

The Clinical Operations Team at Tonix Pharmaceuticals oversees the planning, execution, and management of clinical trials for the company's innovative pharmaceutical products. This includes coordinating with regulatory bodies, ensuring compliance with clinical protocols, managing trial sites, and handling data collection. Their goal is to efficiently bring new treatments, such as Tonmya and TNX-601, from concept to market to address major public health challenges.

Clinical Operations Team

The Quality Control and Assurance team at Tonix Pharmaceuticals ensures that all pharmaceutical products, including Tonmya and TNX-601, meet rigorous safety and efficacy standards. They oversee the entire product development lifecycle, from research and development to commercial operations, ensuring compliance with Good Clinical Practice (GCP) guidelines and regulatory requirements. This team conducts thorough inspections, audits, and testing processes to maintain high-quality standards and regulatory compliance across all operations.

Tonix Pharmaceuticals

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Clinical Operations Team

Quality Control and Assurance

Offices

Tonix Pharmaceuticals

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Clinical Operations Team

Quality Control and Assurance

Offices

Related companies